Feed Preview

Fast Growing

Biomarkers for Type 2 Diabetes

Biomarkers for Type 2 Diabetes diagram by Abbasi et al, PLOS One
Abbasi et al, PLOS One

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Top 20 most recent papers
Journal of Diabetes Investigation

Alcohol-induced impaired insulin secretion in a Japanese population: Five-year follow-up in the Gifu Diabetes Study

Journal of Diabetes InvestigationApril 1, 2020
Natsumi UedaGifu Diabetes Study Group
4
Journal of Diabetes and Its Complications

Once-weekly dulaglutide versus insulin glargine in the early control of fasting serum glucose and HbA1c

Journal of Diabetes and Its ComplicationsMarch 30, 2020
Irene RomeraJesús Reviriego
Frontiers in Endocrinology

Role of the Gut in Diabetic Dyslipidemia

Frontiers in EndocrinologyApril 2, 2020
Priska StahelGary F Lewis
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy

Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice

Diabetes, Metabolic Syndrome and Obesity : Targets and TherapyApril 2, 2020
Aline David-SilvaUbiratan Fabres Machado
Journal of Clinical Medicine

Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes

Journal of Clinical MedicineApril 1, 2020
Angelo Maria PattiFerdinando Mannello

See more papers from this feed

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

© 2020 Meta ULC. All rights reserved
/feed-previews/biomarkers-for-type-2-diabetes/96a56e2d-18c4-4ec1-a700-d64be2f4efb1